NCT00171639 - The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

zoledronic acid

Trial Locations (7)

VAWNY Buffalo, Buffalo

Washington VA Medical Center, Washington D.C.

Hines VA Medical Center, Hines

West Side VMAC, Chicago

Kansas City VMAC, Kansas City

Southern AZ VA Health Care System, Tucson

VA Medical Center-Long Beach, Long Beach